Interestingly, one third of endocrine resistant breast cancers are ERα-positive (Encarnación et al, 1993; Johnston et al, 1995), raising questions about the mechanisms which allow them to keep proliferating despite interfering with the estrogen response. The gene discussed is ESR1; the disease is breast cancer.